Affordable Access

Publisher Website

Stereoselective Biotransformations in Synthesis of Some Pharmaceutical Intermediates

Authors
Publisher
Elsevier Science & Technology
Identifiers
DOI: 10.1016/s0065-2164(08)70224-7
Disciplines
  • Biology
  • Chemistry
  • Pharmacology

Abstract

Publisher Summary The chapter provides some specific examples of stereoselective biotransformations to prepare chiral intermediates required for the synthesis of pharmaceutical drugs. The search for selective enzyme inhibitors and receptor agonists or antagonists is one of the keys for target-oriented research in the pharmaceutical industry. It is now known that in many cases only one stereoisomer of a drug substance is required for efficacy and the other stereoisomer is either inactive or exhibits considerably reduced activity. New drugs for the clinic should be homochiral to avoid the possibility of unnecessary side effects due to an undesirable stereoisomer. Chiral drug intermediates can be prepared by different routes. One is to obtain them from naturally occurring chiral synthons mainly produced by fermentation processes. Second is to carry out resolution of racemic compounds. This can be achieved by preferential crystallization of stereoisomers or diastereoisomers and by kinetic resolution of racemic compounds by chemical or biocatalytic methods. Chiral synthons can also be prepared by asymmetric synthesis by either chemical or biocatalytic processes using microbial cells or enzymes derived therefrom. The advantages of microbial or enzyme-catalyzed reactions over chemical reactions are that they are stereoselective and that they can be carried out at ambient temperature and atmospheric pressure. This minimizes problems of isomerization, racemization, epimerization, and rearrangement that generally occur during chemical processes. Microbial cells or enzymes derived therefrom can be immobilized and reused during many cycles. The chapter provides some specific examples of stereoselective biotransformations to prepare chiral intermediates required for the synthesis of pharmaceutical drugs.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Stereoselective biotransformations in synthesis of...

on Advances in applied microbiolo... 1997

Application of biocatalysis and biotransformations...

on Drug Discovery Today Jan 01, 1997

Chemo-enzymatic synthesis of pharmaceutical interm...

on Expert Opinion on Drug Discove... February 2008

Enzymatic synthesis of chiral intermediates for ph...

on Journal of industrial microbio... May 2003
More articles like this..